Abeona Therapeutics (ABEO) Long-Term Debt Issuances (2020 - 2024)
Abeona Therapeutics (ABEO) recorded quarterly Long-Term Debt Issuances of $20.0 million in Q1 2024, up 47719.05% quarter-over-quarter from -$42000.0 in Q2 2020.
Abeona Therapeutics (ABEO) Long-Term Debt Issuances (2020 - 2024) Analysis & Trends
Abeona Therapeutics' Long-Term Debt Issuances history runs 2 years deep, the most recent figure standing at $20.0 million for Q1 2024.
- In Q1 2024, Long-Term Debt Issuances changed N/A year-over-year to $20.0 million; the TTM figure through Dec 2024 stood at $20.0 million (changed N/A YoY), while the FY2024 annual figure was $20.0 million, changed N/A from the prior year.
- Long-Term Debt Issuances was $20.0 million for Q1 2024 at Abeona Therapeutics, up from -$42000.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $20.0 million in Q1 2024 to a low of -$42000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 2.73 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 20.00 Mn |
| Mar 31, 2024 | 20.00 Mn |
| Jun 30, 2020 | -42,000.00 |
| Jun 30, 2020 | -42,000.00 |